• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Radio Pharmaceutical Market Share

    ID: MRFR/HC/1119-CR
    200 Pages
    Rahul Gotadki
    July 2025

    Radiopharmaceuticals Market Research Report By Application (Diagnosis, Therapy, Research), By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Radiopharmaceutical Class (Radioisotopes, Radiolabeled Compounds, Radiopharmaceutical Generators), By End Use (Hospitals, Diagnostic Imaging Centers, Research Institutions) and By Regional (North America, Europe, South America...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Radio Pharmaceutical Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    Radio Pharmaceutical Market Share Analysis

    The Blue Biotechnology market, encompassing marine-based biotechnological applications, is gaining prominence with the exploration of marine resources for different modern and scientific purposes. Companies in this market are deploying diverse market share situating strategies to establish a critical traction. Companies are focusing on biodiscovery efforts, exploring marine creatures for unique bioactive mixtures and enzymes. This strategy positions them as pioneers in the identification and development of novel marine-derived items, catering to industries like pharmaceuticals, cosmetics, and agriculture. A key market situating strategy involves zeroing in on drug discovery and development from marine sources. Companies specializing in the identification and separation of bioactive mixtures from marine organic entities contribute to the pharmaceutical business' quest for innovative medications, elevating their status in the Blue Biotechnology market. Recognizing the importance of sustainable aquaculture, companies are developing bioproducts to enhance the health and efficiency of aquaculture and fisheries. This strategy lines up with the increasing demand for environmentally friendly arrangements in the seafood business, adding to market share development. Addressing environmental concerns, companies are situating themselves as leaders in bioremediation and contamination control utilizing marine biotechnology. Developing answers for mitigate the effect of toxins on marine ecosystems establishes these companies as environmentally cognizant entities, fostering positive brand perception. Companies are investing in marine genomics to understand the genetic makeup of marine life forms. This strategy enables the identification of valuable traits and genes for potential biotechnological applications. Companies at the forefront of marine genomics contribute to advancements in Blue Biotechnology. Responding to the developing demand for regular and health-focused items, companies are commercializing marine-derived nutraceuticals. Extracting bioactive compounds with potential health benefits positions these companies in the lucrative market for functional foods and dietary supplements.

    Market Summary

    The Global Radiopharmaceuticals Market is projected to grow from 7.09 USD Billion in 2024 to 18.52 USD Billion by 2035.

    Key Market Trends & Highlights

    Radiopharmaceuticals Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 5.52% from 2025 to 2035. By 2035, the market valuation is anticipated to reach 12.3 USD Billion, indicating robust growth. in 2024, the market is valued at 7.09 USD Billion, reflecting a strong foundation for future expansion. Growing adoption of advanced imaging techniques due to increasing prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 7.09 (USD Billion)
    2035 Market Size 18.52 (USD Billion)
    CAGR (2025-2035) 9.12%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Bracco Imaging, Novartis, Bayer, General Electric, Draximage, Actinium Pharmaceuticals, Lantheus Medical Imaging, Siemens Healthineers, NorthStar Medical Radioisotopes, Ion Beam Applications, Cardinal Health, TheraSource</p>

    Market Trends

    The future of the Radiopharmaceuticals Market is being influenced by a number of significant trends. The demand for targeted therapies that radiopharmaceuticals provide, particularly in oncology, is a substantial trend. The sophisticated radiopharmaceuticals that can specifically target cancer cells while sparing healthy tissues have been developed as a result of the growing momentum of the precision medicine approach.

    <p>The Global Radiopharmaceuticals Market is poised for substantial growth, driven by advancements in nuclear medicine and an increasing demand for targeted therapies in oncology.</p>

    U.S. Department of Energy

    Radio Pharmaceutical Market Market Drivers

    Growing Geriatric Population

    The aging population globally is a significant driver for the Global Radiopharmaceuticals Market Industry. As individuals age, the prevalence of chronic diseases, including cancer and cardiovascular conditions, increases, necessitating advanced diagnostic and therapeutic options. The World Population Prospects indicate that the number of people aged 65 and older is projected to double by 2050. This demographic shift is likely to enhance the demand for radiopharmaceuticals, as they play a crucial role in managing age-related health issues. Consequently, the market is expected to expand, reaching 12.3 USD Billion by 2035, reflecting the increasing healthcare needs of the elderly.

    Market Trends and Projections

    Increasing Incidence of Cancer

    The Global Radiopharmaceuticals Market Industry is experiencing growth due to the rising incidence of cancer worldwide. According to the World Health Organization, cancer cases are expected to rise significantly, leading to an increased demand for targeted therapies. Radiopharmaceuticals, which are used in both diagnosis and treatment, are becoming essential in oncology. The market is projected to reach 6.81 USD Billion in 2024, driven by advancements in radiotherapy techniques and the development of new radiopharmaceuticals. This trend indicates a growing recognition of the importance of precision medicine in cancer treatment, thereby enhancing the market's potential.

    Rising Investment in Nuclear Medicine

    Investment in nuclear medicine is on the rise, significantly impacting the Global Radiopharmaceuticals Market Industry. Governments and private sectors are increasingly funding research and development initiatives aimed at enhancing radiopharmaceutical applications. This financial support is crucial for developing new compounds and improving existing ones, which can lead to better diagnostic and therapeutic outcomes. As a result, the market is poised for growth, with projections indicating a potential market size of 12.3 USD Billion by 2035. This trend underscores the commitment to advancing nuclear medicine and its role in modern healthcare.

    Regulatory Support for Radiopharmaceuticals

    Regulatory bodies are increasingly supporting the development and approval of radiopharmaceuticals, which is beneficial for the Global Radiopharmaceuticals Market Industry. Streamlined approval processes and guidelines for manufacturing and quality control are encouraging innovation in this field. For instance, the U.S. Food and Drug Administration has implemented programs to expedite the review of new radiopharmaceuticals, fostering a conducive environment for market growth. This regulatory support is likely to enhance the availability of novel therapies, thereby expanding the market's reach and contributing to its anticipated growth trajectory.

    Technological Advancements in Imaging Techniques

    Technological innovations in imaging techniques are propelling the Global Radiopharmaceuticals Market Industry forward. Enhanced imaging modalities, such as PET and SPECT, are increasingly utilized in conjunction with radiopharmaceuticals, improving diagnostic accuracy and treatment outcomes. The integration of artificial intelligence in imaging analysis further augments the capabilities of these technologies. As a result, the demand for radiopharmaceuticals is likely to rise, with the market anticipated to grow at a CAGR of 5.52% from 2025 to 2035. This growth reflects the industry's commitment to providing more effective and efficient diagnostic tools, ultimately benefiting patient care.

    Market Segment Insights

    Radiopharmaceuticals Market Application Insights

    <p>The Radiopharmaceuticals Market has shown notable growth, especially concerning its Application segment, which is segmented into Diagnosis, Therapy, and Research. In 2024, the market valuation is projected to reach 6.81 USD Billion, reflecting the increasing utilization of radiopharmaceuticals in various medical applications. With the effective implementation of these technologies, the market for Diagnosis alone is valued at 2.73 USD billion and is expected to rise significantly to 4.84 USD billion by 2035.</p>

    <p>This segment plays a crucial role in the early detection of diseases, such as cancer, which enhances treatment outcomes and patient survival rates. As the prevalence of chronic diseases escalates globally, the Demand for diagnostic radiopharmaceuticals is anticipated to witness substantial growth, solidifying its majority holding within the overall market. The Therapy segment is also significant, being valued at 2.94 USD Billion in 2024, with expectations to grow to 5.25 USD Billion in 2035.</p>

    <p>This segment is integral to the treatment of diseases, leveraging targeted therapy approaches that deliver precise doses of radiopharmaceuticals to affected tissues, ensuring effective treatment while minimizing side effects. The Research segment, while comparatively smaller, holds a value of 1.14 USD billion in 2024 and is projected to increase to 2.11 USD billion by 2035, highlighting the ongoing developments in radiopharmaceutical innovations. Research drives the development of novel therapeutics and enhances the understanding of disease mechanisms, contributing greatly to advancements in medical science.</p>

    <p>Moreover, as healthcare providers and institutions continue to seek more effective diagnostics and therapies, the demand for these applications is set to increase steadily. However, challenges such as regulatory complexities and the high cost of radiopharmaceutical production may hinder growth. Nevertheless, the rising prevalence of cancer and other infectious diseases presents significant opportunities for enhancement in the Diagnosis and Therapy segments of the Global Radiopharmaceuticals Market. Insights from current market trends reveal that expanding healthcare accessibility and enhanced patient awareness are crucial drivers that are anticipated to propel further innovation and growth in this vital industry.</p>

    <p>As such, the market is poised for significant advancements, reinforcing the relevance of the Application segment in addressing healthcare challenges globally.</p>

    <p>Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review</p>

    Radiopharmaceuticals Market Type Insights

    <p>The Radiopharmaceuticals Market is poised for substantial growth, with a projected value of 6.81 billion USD by 2024. This market is primarily segmented into two key types: Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals.</p>

    <p>Diagnostic Radiopharmaceuticals play a critical role in healthcare by offering detailed imaging capabilities, thereby aiding in the early detection and diagnosis of various diseases, particularly cancers and cardiovascular conditions. On the other hand, Therapeutic Radiopharmaceuticals are essential for treatment purposes, notably in areas such as oncology and pain management, where targeted radiotherapy can significantly enhance patient outcomes.</p>

    <p>The increasing prevalence of chronic diseases, coupled with advancements in medical imaging technology, is driving the growth of these segments. Government initiatives promoting early disease detection further underscore the importance of Diagnostic Radiopharmaceuticals, while ongoing Research and Development efforts enhance the efficacy of therapeutic applications.</p>

    Radiopharmaceuticals Market Radiopharmaceutical Class Insights

    <p>The Radiopharmaceuticals Market is set to experience substantial growth, with a projected valuation of 6.81 billion USD in 2024 and a significant rise to 12.3 billion USD by 2035. A key component of this market is the Radiopharmaceutical Class, which encompasses various categories including Radioisotopes, Radiolabeled Compounds, and Radiopharmaceutical Generators.</p>

    <p>Radioisotopes play a critical role in diagnostic imaging and cancer treatment, making them a pivotal element in the healthcare system. Radiolabeled Compounds are increasingly used in Research and Development for targeted therapies, enhancing their importance in modern medicine.</p>

    <p>Furthermore, Radiopharmaceutical Generators are essential for producing radionuclides on-site, addressing the growing demand for efficient and timely medical applications. The market is witnessing notable trends driven by an increase in cancer incidence, the aging population, and technological advancements in imaging technologies.</p>

    <p>Insights into the Radiopharmaceuticals Market revenue and segmentation reveal a landscape poised for significant transformation, driven by increasing investments in the sector and a growing emphasis on precision medicine.</p>

    Radiopharmaceuticals Market End Use Insights

    <p>The Radiopharmaceuticals Market is projected to reach a value of 6.81 billion USD by 2024, driven by various end-use sectors such as Hospitals, Diagnostic Imaging Centers, and Research Institutions.</p>

    <p>Hospitals play a crucial role in this landscape, utilizing radiopharmaceuticals for <a href="https://www.marketresearchfuture.com/reports/diagnostic-imaging-market-6765">diagnostic imaging</a> and therapeutic purposes, which significantly enhances patient care and treatment outcomes. Diagnostic Imaging Centers are also vital, as they specialize in visualizing internal organs and detecting diseases through sophisticated imaging techniques, thereby contributing to early diagnosis and better management of illnesses.</p>

    <p>Research Institutions contribute to the market growth by focusing on the development of new radiopharmaceuticals and innovative therapies, addressing unmet medical needs, and paving the way for advancements in nuclear medicine. Overall, the Radiopharmaceuticals Market segmentation reflects a robust ecosystem, where each segment not only supports but also complements the others, facilitating market growth through increased collaboration and innovation across the industry. The steady advancement in imaging technology, rising incidences of chronic diseases, and the growing importance of personalized medicine are key growth drivers fueling the demand in these end-use sectors globally.</p>

    Get more detailed insights about Radiopharmaceuticals Market Research Report - Forecast to 2035

    Regional Insights

    The Radiopharmaceuticals Market is prominently segmented on a regional basis, with North America leading the way and holding a significant market share valued at 3.06 USD billion in 2024. This dominance is attributed to advanced healthcare infrastructure, a high prevalence of chronic diseases, and a robust Research and Development sector.

    Europe follows closely with a valuation of 2.5 USD Billion in 2024, reflecting strong demand for innovative medical imaging techniques and targeted therapies. South America showcases potential for growth, with a market value of 0.4 USD Billion in 2024, driven by increasing healthcare investments and demand for effective diagnostic solutions.

    The Asia Pacific region also presents growth opportunities, estimated at 0.8 USD Billion in 2024, supported by rising awareness about the benefits of radiopharmaceuticals and increasing cancer incidences. Meanwhile, the Middle East and Africa region, while the least populated in terms of market valuation with 0.05 USD billion in 2024, is gradually adapting to advanced medical practices.

    This diverse landscape within the Radiopharmaceuticals Market speaks to unique regional challenges and opportunities that drive market growth and development across the globe.

    Radiopharmaceuticals Market Regional Insights

    Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

    Key Players and Competitive Insights

    The Radiopharmaceuticals Market has been experiencing substantial growth driven by the rising prevalence of cancer and cardiovascular diseases, alongside advancements in imaging technologies. This market is characterized by a diverse range of players, including both established corporations and emerging biotech companies. The competitive landscape is marked by strategic collaborations, mergers, and acquisition activities, and continuous innovation in product development aimed at enhancing diagnostic and therapeutic capabilities.

    Emphasis on research and development has led to the introduction of novel radiopharmaceuticals, which are increasingly being integrated into standard healthcare practices for improved patient outcomes. Companies are also vying for regulatory approvals and investing in market expansion to secure a more dominant position in this lucrative sector.

    Bracco Imaging has solidified its presence in the Radiopharmaceuticals Market through its strong focus on product innovation and a solid portfolio of imaging agents. The company's strengths lie in its advanced research capabilities and a robust distribution network, which enhances its ability to deliver high-quality products to healthcare providers worldwide. Bracco Imaging has successfully developed a range of radiopharmaceuticals that meet the specific imaging needs of clinicians, thereby making a significant impact in the field of nuclear medicine. Its commitment to fostering partnerships with healthcare institutions and leveraging state-of-the-art technology contributes to the company’s competitive advantage.

    Furthermore, Bracco Imaging's focus on regulatory compliance ensures that it sustains its reputation for safety and efficacy, ultimately reinforcing its status in the global market.

    In the Global Radiopharmaceuticals Market, Novartis distinguishes itself through a combination of innovative therapeutic radiopharmaceuticals and a strong commitment to research and development. The company's key products include radioligand therapies that target specific cancers, demonstrating its focus on precision medicine. Novartis has established a presence in various regions globally, along with strategic partnerships and collaborations to enhance its market reach and product offerings. The company's strengths include its vast resources, extensive clinical trial pipelines, and a strong foothold in the healthcare industry.

    Additionally, Novartis has engaged in several mergers and acquisitions to broaden its portfolio and accelerate the development of advanced radiopharmaceuticals. By continually investing in cutting-edge research and expanding its therapeutic range, Novartis maintains a competitive edge in the global radiopharmaceutical landscape.

    Key Companies in the Radio Pharmaceutical Market market include

    Industry Developments

    The Radiopharmaceuticals Market has witnessed several significant developments recently.

    In January 2024, Novartis obtained FDA approval for the commercial production of Pluvicto at its new radioligand manufacturing facility in Indianapolis, Indiana.

    In February 2024, Bristol-Myers Squibb finalized its $4.1 billion acquisition of RayzeBio, which bolstered its actinium-based radiopharmaceutical pipeline.

    AstraZeneca acquired Fusion Pharmaceuticals for $2.4 billion in March 2024, thereby acquiring access to its FPI-2265 prostate cancer radioconjugate and manufacturing assets.

    Future Outlook

    Radio Pharmaceutical Market Future Outlook

    <p>The Radiopharmaceuticals Market is projected to grow at a 9.12% CAGR from 2025 to 2035, driven by advancements in targeted therapies and increasing diagnostic applications.</p>

    New opportunities lie in:

    • <p>Develop novel radiopharmaceuticals for personalized medicine. Expand production capabilities to meet rising global demand. Leverage AI for enhanced imaging and treatment planning.</p>

    <p>By 2035, the Radiopharmaceuticals Market is expected to achieve substantial growth, reflecting its critical role in modern healthcare.</p>

    Market Segmentation

    Radiopharmaceuticals Market Type Outlook

    • Diagnostic Radiopharmaceuticals
    • Therapeutic Radiopharmaceuticals

    Radiopharmaceuticals Market End Use Outlook

    • Hospitals
    • Diagnostic Imaging Centers
    • Research Institutions

    Radiopharmaceuticals Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Radiopharmaceuticals Market Application Outlook

    • Diagnosis
    • Therapy
    • Research

    Radiopharmaceuticals Market Radiopharmaceutical Class Outlook

    • Radioisotopes
    • Radiolabeled Compounds
    • Radiopharmaceutical Generators

    Report Scope

    Report Attribute/MetricDetails
    Market Size 20247.09(USD Billion)
    Market Size 203518.52 (USD Billion)
    Compound Annual Growth Rate (CAGR)9.12% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledBracco Imaging, Novartis, Bayer, General Electric, Draximage, Actinium Pharmaceuticals, Lantheus Medical Imaging, Siemens Healthineers, NorthStar Medical Radioisotopes, Ion Beam Applications, Cardinal Health, TheraSource
    Segments CoveredApplication, Type, Radiopharmaceutical Class, End Use, Regional
    Key Market OpportunitiesInnovative diagnostic imaging agents, Expansion in targeted therapies, Rising prevalence of cancer, Advancements in manufacturing technologies, and Government funding for research
    Key Market DynamicsTechnological advancements, Rising cancer prevalence, Increasing demand for diagnostics, Growing aging population, Favorable regulatory framework
    Countries CoveredNorth America, Europe, APAC, South America, MEA
    Market Size 20257.74 (USD Billion)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the projected market size of the Radiopharmaceuticals Market in 2024?

    The Radiopharmaceuticals Market is expected to be valued at 6.81 billion USD in 2024.

    What is the expected CAGR for the Radiopharmaceuticals Market from 2025 to 2035?

    The market is anticipated to grow at a CAGR of 5.52% from 2025 to 2035.

    Which region is expected to dominate the Radiopharmaceuticals Market in 2024?

    North America is expected to dominate the market with a value of 3.06 billion USD in 2024.

    How much is the Radiopharmaceuticals Market expected to be valued by 2035?

    The market is projected to reach 12.3 billion USD by 2035.

    What will be the market size for the Diagnosis application segment by 2035?

    The Diagnosis application segment is expected to be valued at 4.84 billion USD by 2035.

    What is the market size of the Therapy application segment in 2024?

    The Therapy application segment is valued at 2.94 billion USD in 2024.

    Which players are major competitors in the Global Radiopharmaceuticals Market?

    Key players include Bracco Imaging, Novartis, Bayer, and General Electric.

    What is the market size for the Research application segment in 2024?

    The Research application segment is anticipated to be valued at 1.14 billion USD in 2024.

    What is the expected market size for Europe in 2035?

    Europe is expected to reach a market value of 4.5 billion USD by 2035.

    How much is the market expected to grow in the Asia Pacific region by 2035?

    The Asia Pacific region is projected to grow to 1.5 billion USD by 2035.

    1. --- "Table of Contents
    2. Executive Summary 
      1. Market Overview 
      2. Key Findings 
      3. Market Segmentation 
      4. Competitive Landscape 
      5. Challenges and Opportunities 
      6. Future Outlook
    3. Market Introduction 
      1. Definition 
      2. Scope of the Study 
        1. Research Objective 
        2. Assumption 
        3. Limitations 
    4. Research Methodology 
      1. Overview 
      2. Data Mining 
      3. Secondary Research 
      4. Primary Research 
        1. Primary Interviews and Information Gathering Process 
        2. Breakdown of Primary Respondents 
      5. Forecasting Model 
      6. Market Size Estimation 
        1. Bottom-up Approach 
        2. Top-Down Approach 
      7. Data Triangulation 
      8. Validation
    5. MARKET DYNAMICS 
      1. Overview 
      2. Drivers 
      3. Restraints 
      4. Opportunities 
    6. MARKET FACTOR ANALYSIS 
      1. Value chain Analysis 
      2. Porter's Five Forces Analysis 
        1. Bargaining Power of Suppliers 
        2. Bargaining Power of Buyers 
        3. Threat of New Entrants 
        4. Threat of Substitutes 
        5. Intensity of Rivalry 
      3. COVID-19 Impact Analysis 
        1. Market Impact Analysis 
        2. Regional Impact 
        3. Opportunity and Threat Analysis
    7. RADIOPHARMACEUTICALS MARKET, BY APPLICATION (USD BILLION) 
      1. Diagnosis 
      2. Therapy 
      3. Research 
    8. RADIOPHARMACEUTICALS MARKET, BY TYPE (USD BILLION) 
      1. Diagnostic Radiopharmaceuticals 
      2. Therapeutic Radiopharmaceuticals 
    9. RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS (USD BILLION) 
      1. Radioisotopes 
      2. Radiolabeled Compounds 
      3. Radiopharmaceutical Generators 
    10. RADIOPHARMACEUTICALS MARKET, BY END USE (USD BILLION) 
      1. Hospitals 
      2. Diagnostic Imaging Centers 
      3. Research Institutions 
    11. RADIOPHARMACEUTICALS MARKET, BY REGIONAL (USD BILLION) 
      1. North America 
        1. US 
        2. Canada 
      2. Europe 
        1. Germany 
        2. UK 
        3. France 
        4. Russia 
        5. Italy 
        6. Spain 
        7. Rest of Europe 
      3. APAC 
        1. China 
        2. India 
        3. Japan 
        4. South Korea 
        5. Malaysia 
        6. Thailand 
        7. Indonesia 
        8. Rest of APAC 
      4. South America 
        1. Brazil 
        2. Mexico 
        3. Argentina 
        4. Rest of South America 
      5. MEA 
        1. GCC Countries 
        2. South Africa 
        3. Rest of MEA
    12. Competitive Landscape 
      1. Overview 
      2. Competitive Analysis 
      3. Market share Analysis 
      4. Major Growth Strategy in the Radiopharmaceuticals Market 
      5. Competitive Benchmarking 
      6. Leading Players in Terms of Number of Developments in the Radiopharmaceuticals Market 
      7. Key developments and growth strategies 
        1. New Product Launch/Service Deployment 
        2. Merger & Acquisitions 
        3. Joint Ventures 
      8. Major Players Financial Matrix 
        1. Sales and Operating Income 
        2. Major Players R&D Expenditure. 2023 
    13. COMPANY PROFILES 
      1. Bracco Imaging 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      2. Novartis 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      3. Bayer 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      4. General Electric 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      5. Draximage 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      6. Actinium Pharmaceuticals 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      7. Lantheus Medical Imaging 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      8. Siemens Healthineers 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      9. Elekta 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      10. NorthStar Medical Radioisotopes 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      11. Ion Beam Applications 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      12. Cardinal Health 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      13. TheraSource 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      14. BristolMyers Squibb 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      15. AbbVie 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
    14. APPENDIX 
      1. References 
      2. Related Reports 
    15. List of Tables and Figures
      1. LIST OF TABLES
      2. TABLE 1. LIST OF ASSUMPTIONS 
      3. TABLE 2. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      4. TABLE 3. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      5. TABLE 4. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      6. TABLE 5. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      7. TABLE 6. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      8. TABLE 7. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      9. TABLE 8. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      10. TABLE 9. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      11. TABLE 10. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      12. TABLE 11. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      13. TABLE 12. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      14. TABLE 13. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      15. TABLE 14. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      16. TABLE 15. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      17. TABLE 16. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      18. TABLE 17. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      19. TABLE 18. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      20. TABLE 19. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      21. TABLE 20. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      22. TABLE 21. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      23. TABLE 22. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      24. TABLE 23. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      25. TABLE 24. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      26. TABLE 25. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      27. TABLE 26. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      28. TABLE 27. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      29. TABLE 28. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      30. TABLE 29. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      31. TABLE 30. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      32. TABLE 31. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      33. TABLE 32. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      34. TABLE 33. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      35. TABLE 34. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      36. TABLE 35. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      37. TABLE 36. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      38. TABLE 37. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      39. TABLE 38. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      40. TABLE 39. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      41. TABLE 40. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      42. TABLE 41. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      43. TABLE 42. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      44. TABLE 43. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      45. TABLE 44. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      46. TABLE 45. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      47. TABLE 46. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      48. TABLE 47. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      49. TABLE 48. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      50. TABLE 49. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      51. TABLE 50. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      52. TABLE 51. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      53. TABLE 52. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      54. TABLE 53. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      55. TABLE 54. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      56. TABLE 55. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      57. TABLE 56. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      58. TABLE 57. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      59. TABLE 58. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      60. TABLE 59. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      61. TABLE 60. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      62. TABLE 61. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      63. TABLE 62. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      64. TABLE 63. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      65. TABLE 64. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      66. TABLE 65. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      67. TABLE 66. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      68. TABLE 67. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      69. TABLE 68. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      70. TABLE 69. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      71. TABLE 70. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      72. TABLE 71. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      73. TABLE 72. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      74. TABLE 73. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      75. TABLE 74. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      76. TABLE 75. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      77. TABLE 76. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      78. TABLE 77. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      79. TABLE 78. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      80. TABLE 79. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      81. TABLE 80. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      82. TABLE 81. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      83. TABLE 82. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      84. TABLE 83. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      85. TABLE 84. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      86. TABLE 85. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      87. TABLE 86. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      88. TABLE 87. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      89. TABLE 88. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      90. TABLE 89. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      91. TABLE 90. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      92. TABLE 91. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      93. TABLE 92. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      94. TABLE 93. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      95. TABLE 94. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      96. TABLE 95. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      97. TABLE 96. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      98. TABLE 97. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      99. TABLE 98. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      100. TABLE 99. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      101. TABLE 100. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      102. TABLE 101. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      103. TABLE 102. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      104. TABLE 103. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      105. TABLE 104. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      106. TABLE 105. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      107. TABLE 106. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      108. TABLE 107. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      109. TABLE 108. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      110. TABLE 109. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      111. TABLE 110. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      112. TABLE 111. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      113. TABLE 112. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      114. TABLE 113. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      115. TABLE 114. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      116. TABLE 115. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      117. TABLE 116. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      118. TABLE 117. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      119. TABLE 118. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      120. TABLE 119. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      121. TABLE 120. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      122. TABLE 121. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      123. TABLE 122. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      124. TABLE 123. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      125. TABLE 124. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      126. TABLE 125. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      127. TABLE 126. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      128. TABLE 127. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      129. TABLE 128. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      130. TABLE 129. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      131. TABLE 130. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      132. TABLE 131. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      133. TABLE 132. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      134. TABLE 133. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      135. TABLE 134. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      136. TABLE 135. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      137. TABLE 136. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      138. TABLE 137. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      139. TABLE 138. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      140. TABLE 139. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      141. TABLE 140. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      142. TABLE 141. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      143. TABLE 142. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      144. TABLE 143. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS) 
      145. TABLE 144. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS) 
      146. TABLE 145. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS) 
      147. TABLE 146. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      148. TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL 
      149. TABLE 148. ACQUISITION/PARTNERSHIP                             LIST OF FIGURES
      150. FIGURE 1. MARKET SYNOPSIS 
      151. FIGURE 2. NORTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS 
      152. FIGURE 3. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      153. FIGURE 4. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      154. FIGURE 5. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      155. FIGURE 6. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      156. FIGURE 7. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      157. FIGURE 8. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      158. FIGURE 9. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      159. FIGURE 10. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      160. FIGURE 11. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      161. FIGURE 12. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      162. FIGURE 13. EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS 
      163. FIGURE 14. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      164. FIGURE 15. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      165. FIGURE 16. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      166. FIGURE 17. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      167. FIGURE 18. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      168. FIGURE 19. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      169. FIGURE 20. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      170. FIGURE 21. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      171. FIGURE 22. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      172. FIGURE 23. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      173. FIGURE 24. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      174. FIGURE 25. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      175. FIGURE 26. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      176. FIGURE 27. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      177. FIGURE 28. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      178. FIGURE 29. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      179. FIGURE 30. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      180. FIGURE 31. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      181. FIGURE 32. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      182. FIGURE 33. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      183. FIGURE 34. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      184. FIGURE 35. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      185. FIGURE 36. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      186. FIGURE 37. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      187. FIGURE 38. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      188. FIGURE 39. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      189. FIGURE 40. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      190. FIGURE 41. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      191. FIGURE 42. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      192. FIGURE 43. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      193. FIGURE 44. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      194. FIGURE 45. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      195. FIGURE 46. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      196. FIGURE 47. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      197. FIGURE 48. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      198. FIGURE 49. APAC RADIOPHARMACEUTICALS MARKET ANALYSIS 
      199. FIGURE 50. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      200. FIGURE 51. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      201. FIGURE 52. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      202. FIGURE 53. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      203. FIGURE 54. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      204. FIGURE 55. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      205. FIGURE 56. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      206. FIGURE 57. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      207. FIGURE 58. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      208. FIGURE 59. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      209. FIGURE 60. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      210. FIGURE 61. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      211. FIGURE 62. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      212. FIGURE 63. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      213. FIGURE 64. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      214. FIGURE 65. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      215. FIGURE 66. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      216. FIGURE 67. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      217. FIGURE 68. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      218. FIGURE 69. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      219. FIGURE 70. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      220. FIGURE 71. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      221. FIGURE 72. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      222. FIGURE 73. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      223. FIGURE 74. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      224. FIGURE 75. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      225. FIGURE 76. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      226. FIGURE 77. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      227. FIGURE 78. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      228. FIGURE 79. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      229. FIGURE 80. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      230. FIGURE 81. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      231. FIGURE 82. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      232. FIGURE 83. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      233. FIGURE 84. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      234. FIGURE 85. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      235. FIGURE 86. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      236. FIGURE 87. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      237. FIGURE 88. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      238. FIGURE 89. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      239. FIGURE 90. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS 
      240. FIGURE 91. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      241. FIGURE 92. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      242. FIGURE 93. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      243. FIGURE 94. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      244. FIGURE 95. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      245. FIGURE 96. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      246. FIGURE 97. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      247. FIGURE 98. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      248. FIGURE 99. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      249. FIGURE 100. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      250. FIGURE 101. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      251. FIGURE 102. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      252. FIGURE 103. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      253. FIGURE 104. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      254. FIGURE 105. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      255. FIGURE 106. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      256. FIGURE 107. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      257. FIGURE 108. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      258. FIGURE 109. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      259. FIGURE 110. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      260. FIGURE 111. MEA RADIOPHARMACEUTICALS MARKET ANALYSIS 
      261. FIGURE 112. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      262. FIGURE 113. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      263. FIGURE 114. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      264. FIGURE 115. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      265. FIGURE 116. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      266. FIGURE 117. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      267. FIGURE 118. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      268. FIGURE 119. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      269. FIGURE 120. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      270. FIGURE 121. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      271. FIGURE 122. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION 
      272. FIGURE 123. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE 
      273. FIGURE 124. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS 
      274. FIGURE 125. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE 
      275. FIGURE 126. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL 
      276. FIGURE 127. KEY BUYING CRITERIA OF RADIOPHARMACEUTICALS MARKET 
      277. FIGURE 128. RESEARCH PROCESS OF MRFR 
      278. FIGURE 129. DRO ANALYSIS OF RADIOPHARMACEUTICALS MARKET 
      279. FIGURE 130. DRIVERS IMPACT ANALYSIS: RADIOPHARMACEUTICALS MARKET 
      280. FIGURE 131. RESTRAINTS IMPACT ANALYSIS: RADIOPHARMACEUTICALS MARKET 
      281. FIGURE 132. SUPPLY / VALUE CHAIN: RADIOPHARMACEUTICALS MARKET 
      282. FIGURE 133. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2025 (% SHARE) 
      283. FIGURE 134. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions) 
      284. FIGURE 135. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2025 (% SHARE) 
      285. FIGURE 136. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2019 TO 2035 (USD Billions) 
      286. FIGURE 137. RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS, 2025 (% SHARE) 
      287. FIGURE 138. RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS, 2019 TO 2035 (USD Billions) 
      288. FIGURE 139. RADIOPHARMACEUTICALS MARKET, BY END USE, 2025 (% SHARE) 
      289. FIGURE 140. RADIOPHARMACEUTICALS MARKET, BY END USE, 2019 TO 2035 (USD Billions) 
      290. FIGURE 141. RADIOPHARMACEUTICALS MARKET, BY REGIONAL, 2025 (% SHARE) 
      291. FIGURE 142. RADIOPHARMACEUTICALS MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions) 
      292. FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS"

    Radiopharmaceuticals Market Segmentation

    • Radiopharmaceuticals Market By Application (USD Billion, 2019-2035)
      • Diagnosis
      • Therapy
      • Research
    • Radiopharmaceuticals Market By Type (USD Billion, 2019-2035)
      • Diagnostic Radiopharmaceuticals
      • Therapeutic Radiopharmaceuticals
    • Radiopharmaceuticals Market By Radiopharmaceutical Class (USD Billion, 2019-2035)
      • Radioisotopes
      • Radiolabeled Compounds
      • Radiopharmaceutical Generators
    • Radiopharmaceuticals Market By End Use (USD Billion, 2019-2035)
      • Hospitals
      • Diagnostic Imaging Centers
      • Research Institutions
    • Radiopharmaceuticals Market By Regional (USD Billion, 2019-2035)
      • North America
      • Europe
      • South America
      • Asia Pacific
      • Middle East and Africa

    Radiopharmaceuticals Market Regional Outlook (USD Billion, 2019-2035)

    • North America Outlook (USD Billion, 2019-2035)
      • North America Radiopharmaceuticals Market by Application Type
        • Diagnosis
        • Therapy
        • Research
      • North America Radiopharmaceuticals Market by Type
        • Diagnostic Radiopharmaceuticals
        • Therapeutic Radiopharmaceuticals
      • North America Radiopharmaceuticals Market by Radiopharmaceutical Class Type
        • Radioisotopes
        • Radiolabeled Compounds
        • Radiopharmaceutical Generators
      • North America Radiopharmaceuticals Market by End Use Type
        • Hospitals
        • Diagnostic Imaging Centers
        • Research Institutions
      • North America Radiopharmaceuticals Market by Regional Type
        • US
        • Canada
      • US Outlook (USD Billion, 2019-2035)
      • US Radiopharmaceuticals Market by Application Type
        • Diagnosis
        • Therapy
        • Research
      • US Radiopharmaceuticals Market by Type
        • Diagnostic Radiopharmaceuticals
        • Therapeutic Radiopharmaceuticals
      • US Radiopharmaceuticals Market by Radiopharmaceutical Class Type
        • Radioisotopes
        • Radiolabeled Compounds
        • Radiopharmaceutical Generators
      • US Radiopharmaceuticals Market by End Use Type
        • Hospitals
        • Diagnostic Imaging Centers
        • Research Institutions
      • CANADA Outlook (USD Billion, 2019-2035)
      • CANADA Radiopharmaceuticals Market by Application Type
        • Diagnosis
        • Therapy
        • Research
      • CANADA Radiopharmaceuticals Market by Type
        • Diagnostic Radiopharmaceuticals
        • Therapeutic Radiopharmaceuticals
      • CANADA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
        • Radioisotopes
        • Radiolabeled Compounds
        • Radiopharmaceutical Generators
      • CANADA Radiopharmaceuticals Market by End Use Type
        • Hospitals
        • Diagnostic Imaging Centers
        • Research Institutions
      • Europe Outlook (USD Billion, 2019-2035)
        • Europe Radiopharmaceuticals Market by Application Type
          • Diagnosis
          • Therapy
          • Research
        • Europe Radiopharmaceuticals Market by Type
          • Diagnostic Radiopharmaceuticals
          • Therapeutic Radiopharmaceuticals
        • Europe Radiopharmaceuticals Market by Radiopharmaceutical Class Type
          • Radioisotopes
          • Radiolabeled Compounds
          • Radiopharmaceutical Generators
        • Europe Radiopharmaceuticals Market by End Use Type
          • Hospitals
          • Diagnostic Imaging Centers
          • Research Institutions
        • Europe Radiopharmaceuticals Market by Regional Type
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Spain
          • Rest of Europe
        • GERMANY Outlook (USD Billion, 2019-2035)
        • GERMANY Radiopharmaceuticals Market by Application Type
          • Diagnosis
          • Therapy
          • Research
        • GERMANY Radiopharmaceuticals Market by Type
          • Diagnostic Radiopharmaceuticals
          • Therapeutic Radiopharmaceuticals
        • GERMANY Radiopharmaceuticals Market by Radiopharmaceutical Class Type
          • Radioisotopes
          • Radiolabeled Compounds
          • Radiopharmaceutical Generators
        • GERMANY Radiopharmaceuticals Market by End Use Type
          • Hospitals
          • Diagnostic Imaging Centers
          • Research Institutions
        • UK Outlook (USD Billion, 2019-2035)
        • UK Radiopharmaceuticals Market by Application Type
          • Diagnosis
          • Therapy
          • Research
        • UK Radiopharmaceuticals Market by Type
          • Diagnostic Radiopharmaceuticals
          • Therapeutic Radiopharmaceuticals
        • UK Radiopharmaceuticals Market by Radiopharmaceutical Class Type
          • Radioisotopes
          • Radiolabeled Compounds
          • Radiopharmaceutical Generators
        • UK Radiopharmaceuticals Market by End Use Type
          • Hospitals
          • Diagnostic Imaging Centers
          • Research Institutions
        • FRANCE Outlook (USD Billion, 2019-2035)
        • FRANCE Radiopharmaceuticals Market by Application Type
          • Diagnosis
          • Therapy
          • Research
        • FRANCE Radiopharmaceuticals Market by Type
          • Diagnostic Radiopharmaceuticals
          • Therapeutic Radiopharmaceuticals
        • FRANCE Radiopharmaceuticals Market by Radiopharmaceutical Class Type
          • Radioisotopes
          • Radiolabeled Compounds
          • Radiopharmaceutical Generators
        • FRANCE Radiopharmaceuticals Market by End Use Type
          • Hospitals
          • Diagnostic Imaging Centers
          • Research Institutions
        • RUSSIA Outlook (USD Billion, 2019-2035)
        • RUSSIA Radiopharmaceuticals Market by Application Type
          • Diagnosis
          • Therapy
          • Research
        • RUSSIA Radiopharmaceuticals Market by Type
          • Diagnostic Radiopharmaceuticals
          • Therapeutic Radiopharmaceuticals
        • RUSSIA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
          • Radioisotopes
          • Radiolabeled Compounds
          • Radiopharmaceutical Generators
        • RUSSIA Radiopharmaceuticals Market by End Use Type
          • Hospitals
          • Diagnostic Imaging Centers
          • Research Institutions
        • ITALY Outlook (USD Billion, 2019-2035)
        • ITALY Radiopharmaceuticals Market by Application Type
          • Diagnosis
          • Therapy
          • Research
        • ITALY Radiopharmaceuticals Market by Type
          • Diagnostic Radiopharmaceuticals
          • Therapeutic Radiopharmaceuticals
        • ITALY Radiopharmaceuticals Market by Radiopharmaceutical Class Type
          • Radioisotopes
          • Radiolabeled Compounds
          • Radiopharmaceutical Generators
        • ITALY Radiopharmaceuticals Market by End Use Type
          • Hospitals
          • Diagnostic Imaging Centers
          • Research Institutions
        • SPAIN Outlook (USD Billion, 2019-2035)
        • SPAIN Radiopharmaceuticals Market by Application Type
          • Diagnosis
          • Therapy
          • Research
        • SPAIN Radiopharmaceuticals Market by Type
          • Diagnostic Radiopharmaceuticals
          • Therapeutic Radiopharmaceuticals
        • SPAIN Radiopharmaceuticals Market by Radiopharmaceutical Class Type
          • Radioisotopes
          • Radiolabeled Compounds
          • Radiopharmaceutical Generators
        • SPAIN Radiopharmaceuticals Market by End Use Type
          • Hospitals
          • Diagnostic Imaging Centers
          • Research Institutions
        • REST OF EUROPE Outlook (USD Billion, 2019-2035)
        • REST OF EUROPE Radiopharmaceuticals Market by Application Type
          • Diagnosis
          • Therapy
          • Research
        • REST OF EUROPE Radiopharmaceuticals Market by Type
          • Diagnostic Radiopharmaceuticals
          • Therapeutic Radiopharmaceuticals
        • REST OF EUROPE Radiopharmaceuticals Market by Radiopharmaceutical Class Type
          • Radioisotopes
          • Radiolabeled Compounds
          • Radiopharmaceutical Generators
        • REST OF EUROPE Radiopharmaceuticals Market by End Use Type
          • Hospitals
          • Diagnostic Imaging Centers
          • Research Institutions
        • APAC Outlook (USD Billion, 2019-2035)
          • APAC Radiopharmaceuticals Market by Application Type
            • Diagnosis
            • Therapy
            • Research
          • APAC Radiopharmaceuticals Market by Type
            • Diagnostic Radiopharmaceuticals
            • Therapeutic Radiopharmaceuticals
          • APAC Radiopharmaceuticals Market by Radiopharmaceutical Class Type
            • Radioisotopes
            • Radiolabeled Compounds
            • Radiopharmaceutical Generators
          • APAC Radiopharmaceuticals Market by End Use Type
            • Hospitals
            • Diagnostic Imaging Centers
            • Research Institutions
          • APAC Radiopharmaceuticals Market by Regional Type
            • China
            • India
            • Japan
            • South Korea
            • Malaysia
            • Thailand
            • Indonesia
            • Rest of APAC
          • CHINA Outlook (USD Billion, 2019-2035)
          • CHINA Radiopharmaceuticals Market by Application Type
            • Diagnosis
            • Therapy
            • Research
          • CHINA Radiopharmaceuticals Market by Type
            • Diagnostic Radiopharmaceuticals
            • Therapeutic Radiopharmaceuticals
          • CHINA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
            • Radioisotopes
            • Radiolabeled Compounds
            • Radiopharmaceutical Generators
          • CHINA Radiopharmaceuticals Market by End Use Type
            • Hospitals
            • Diagnostic Imaging Centers
            • Research Institutions
          • INDIA Outlook (USD Billion, 2019-2035)
          • INDIA Radiopharmaceuticals Market by Application Type
            • Diagnosis
            • Therapy
            • Research
          • INDIA Radiopharmaceuticals Market by Type
            • Diagnostic Radiopharmaceuticals
            • Therapeutic Radiopharmaceuticals
          • INDIA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
            • Radioisotopes
            • Radiolabeled Compounds
            • Radiopharmaceutical Generators
          • INDIA Radiopharmaceuticals Market by End Use Type
            • Hospitals
            • Diagnostic Imaging Centers
            • Research Institutions
          • JAPAN Outlook (USD Billion, 2019-2035)
          • JAPAN Radiopharmaceuticals Market by Application Type
            • Diagnosis
            • Therapy
            • Research
          • JAPAN Radiopharmaceuticals Market by Type
            • Diagnostic Radiopharmaceuticals
            • Therapeutic Radiopharmaceuticals
          • JAPAN Radiopharmaceuticals Market by Radiopharmaceutical Class Type
            • Radioisotopes
            • Radiolabeled Compounds
            • Radiopharmaceutical Generators
          • JAPAN Radiopharmaceuticals Market by End Use Type
            • Hospitals
            • Diagnostic Imaging Centers
            • Research Institutions
          • SOUTH KOREA Outlook (USD Billion, 2019-2035)
          • SOUTH KOREA Radiopharmaceuticals Market by Application Type
            • Diagnosis
            • Therapy
            • Research
          • SOUTH KOREA Radiopharmaceuticals Market by Type
            • Diagnostic Radiopharmaceuticals
            • Therapeutic Radiopharmaceuticals
          • SOUTH KOREA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
            • Radioisotopes
            • Radiolabeled Compounds
            • Radiopharmaceutical Generators
          • SOUTH KOREA Radiopharmaceuticals Market by End Use Type
            • Hospitals
            • Diagnostic Imaging Centers
            • Research Institutions
          • MALAYSIA Outlook (USD Billion, 2019-2035)
          • MALAYSIA Radiopharmaceuticals Market by Application Type
            • Diagnosis
            • Therapy
            • Research
          • MALAYSIA Radiopharmaceuticals Market by Type
            • Diagnostic Radiopharmaceuticals
            • Therapeutic Radiopharmaceuticals
          • MALAYSIA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
            • Radioisotopes
            • Radiolabeled Compounds
            • Radiopharmaceutical Generators
          • MALAYSIA Radiopharmaceuticals Market by End Use Type
            • Hospitals
            • Diagnostic Imaging Centers
            • Research Institutions
          • THAILAND Outlook (USD Billion, 2019-2035)
          • THAILAND Radiopharmaceuticals Market by Application Type
            • Diagnosis
            • Therapy
            • Research
          • THAILAND Radiopharmaceuticals Market by Type
            • Diagnostic Radiopharmaceuticals
            • Therapeutic Radiopharmaceuticals
          • THAILAND Radiopharmaceuticals Market by Radiopharmaceutical Class Type
            • Radioisotopes
            • Radiolabeled Compounds
            • Radiopharmaceutical Generators
          • THAILAND Radiopharmaceuticals Market by End Use Type
            • Hospitals
            • Diagnostic Imaging Centers
            • Research Institutions
          • INDONESIA Outlook (USD Billion, 2019-2035)
          • INDONESIA Radiopharmaceuticals Market by Application Type
            • Diagnosis
            • Therapy
            • Research
          • INDONESIA Radiopharmaceuticals Market by Type
            • Diagnostic Radiopharmaceuticals
            • Therapeutic Radiopharmaceuticals
          • INDONESIA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
            • Radioisotopes
            • Radiolabeled Compounds
            • Radiopharmaceutical Generators
          • INDONESIA Radiopharmaceuticals Market by End Use Type
            • Hospitals
            • Diagnostic Imaging Centers
            • Research Institutions
          • REST OF APAC Outlook (USD Billion, 2019-2035)
          • REST OF APAC Radiopharmaceuticals Market by Application Type
            • Diagnosis
            • Therapy
            • Research
          • REST OF APAC Radiopharmaceuticals Market by Type
            • Diagnostic Radiopharmaceuticals
            • Therapeutic Radiopharmaceuticals
          • REST OF APAC Radiopharmaceuticals Market by Radiopharmaceutical Class Type
            • Radioisotopes
            • Radiolabeled Compounds
            • Radiopharmaceutical Generators
          • REST OF APAC Radiopharmaceuticals Market by End Use Type
            • Hospitals
            • Diagnostic Imaging Centers
            • Research Institutions
          • South America Outlook (USD Billion, 2019-2035)
            • South America Radiopharmaceuticals Market by Application Type
              • Diagnosis
              • Therapy
              • Research
            • South America Radiopharmaceuticals Market by Type
              • Diagnostic Radiopharmaceuticals
              • Therapeutic Radiopharmaceuticals
            • South America Radiopharmaceuticals Market by Radiopharmaceutical Class Type
              • Radioisotopes
              • Radiolabeled Compounds
              • Radiopharmaceutical Generators
            • South America Radiopharmaceuticals Market by End Use Type
              • Hospitals
              • Diagnostic Imaging Centers
              • Research Institutions
            • South America Radiopharmaceuticals Market by Regional Type
              • Brazil
              • Mexico
              • Argentina
              • Rest of South America
            • BRAZIL Outlook (USD Billion, 2019-2035)
            • BRAZIL Radiopharmaceuticals Market by Application Type
              • Diagnosis
              • Therapy
              • Research
            • BRAZIL Radiopharmaceuticals Market by Type
              • Diagnostic Radiopharmaceuticals
              • Therapeutic Radiopharmaceuticals
            • BRAZIL Radiopharmaceuticals Market by Radiopharmaceutical Class Type
              • Radioisotopes
              • Radiolabeled Compounds
              • Radiopharmaceutical Generators
            • BRAZIL Radiopharmaceuticals Market by End Use Type
              • Hospitals
              • Diagnostic Imaging Centers
              • Research Institutions
            • MEXICO Outlook (USD Billion, 2019-2035)
            • MEXICO Radiopharmaceuticals Market by Application Type
              • Diagnosis
              • Therapy
              • Research
            • MEXICO Radiopharmaceuticals Market by Type
              • Diagnostic Radiopharmaceuticals
              • Therapeutic Radiopharmaceuticals
            • MEXICO Radiopharmaceuticals Market by Radiopharmaceutical Class Type
              • Radioisotopes
              • Radiolabeled Compounds
              • Radiopharmaceutical Generators
            • MEXICO Radiopharmaceuticals Market by End Use Type
              • Hospitals
              • Diagnostic Imaging Centers
              • Research Institutions
            • ARGENTINA Outlook (USD Billion, 2019-2035)
            • ARGENTINA Radiopharmaceuticals Market by Application Type
              • Diagnosis
              • Therapy
              • Research
            • ARGENTINA Radiopharmaceuticals Market by Type
              • Diagnostic Radiopharmaceuticals
              • Therapeutic Radiopharmaceuticals
            • ARGENTINA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
              • Radioisotopes
              • Radiolabeled Compounds
              • Radiopharmaceutical Generators
            • ARGENTINA Radiopharmaceuticals Market by End Use Type
              • Hospitals
              • Diagnostic Imaging Centers
              • Research Institutions
            • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
            • REST OF SOUTH AMERICA Radiopharmaceuticals Market by Application Type
              • Diagnosis
              • Therapy
              • Research
            • REST OF SOUTH AMERICA Radiopharmaceuticals Market by Type
              • Diagnostic Radiopharmaceuticals
              • Therapeutic Radiopharmaceuticals
            • REST OF SOUTH AMERICA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
              • Radioisotopes
              • Radiolabeled Compounds
              • Radiopharmaceutical Generators
            • REST OF SOUTH AMERICA Radiopharmaceuticals Market by End Use Type
              • Hospitals
              • Diagnostic Imaging Centers
              • Research Institutions
            • MEA Outlook (USD Billion, 2019-2035)
              • MEA Radiopharmaceuticals Market by Application Type
                • Diagnosis
                • Therapy
                • Research
              • MEA Radiopharmaceuticals Market by Type
                • Diagnostic Radiopharmaceuticals
                • Therapeutic Radiopharmaceuticals
              • MEA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
                • Radioisotopes
                • Radiolabeled Compounds
                • Radiopharmaceutical Generators
              • MEA Radiopharmaceuticals Market by End Use Type
                • Hospitals
                • Diagnostic Imaging Centers
                • Research Institutions
              • MEA Radiopharmaceuticals Market by Regional Type
                • GCC Countries
                • South Africa
                • Rest of MEA
              • GCC COUNTRIES Outlook (USD Billion, 2019-2035)
              • GCC COUNTRIES Radiopharmaceuticals Market by Application Type
                • Diagnosis
                • Therapy
                • Research
              • GCC COUNTRIES Radiopharmaceuticals Market by Type
                • Diagnostic Radiopharmaceuticals
                • Therapeutic Radiopharmaceuticals
              • GCC COUNTRIES Radiopharmaceuticals Market by Radiopharmaceutical Class Type
                • Radioisotopes
                • Radiolabeled Compounds
                • Radiopharmaceutical Generators
              • GCC COUNTRIES Radiopharmaceuticals Market by End Use Type
                • Hospitals
                • Diagnostic Imaging Centers
                • Research Institutions
              • SOUTH AFRICA Outlook (USD Billion, 2019-2035)
              • SOUTH AFRICA Radiopharmaceuticals Market by Application Type
                • Diagnosis
                • Therapy
                • Research
              • SOUTH AFRICA Radiopharmaceuticals Market by Type
                • Diagnostic Radiopharmaceuticals
                • Therapeutic Radiopharmaceuticals
              • SOUTH AFRICA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
                • Radioisotopes
                • Radiolabeled Compounds
                • Radiopharmaceutical Generators
              • SOUTH AFRICA Radiopharmaceuticals Market by End Use Type
                • Hospitals
                • Diagnostic Imaging Centers
                • Research Institutions
              • REST OF MEA Outlook (USD Billion, 2019-2035)
              • REST OF MEA Radiopharmaceuticals Market by Application Type
                • Diagnosis
                • Therapy
                • Research
              • REST OF MEA Radiopharmaceuticals Market by Type
                • Diagnostic Radiopharmaceuticals
                • Therapeutic Radiopharmaceuticals
              • REST OF MEA Radiopharmaceuticals Market by Radiopharmaceutical Class Type
                • Radioisotopes
                • Radiolabeled Compounds
                • Radiopharmaceutical Generators
              • REST OF MEA Radiopharmaceuticals Market by End Use Type
                • Hospitals
                • Diagnostic Imaging Centers
                • Research Institutions
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials